HCG's TMT department is a Centre of Excellence that accelerates oncology research and improves patient treatments and outcomes using a collaborative approach, from bench to bedside and vice-versa.
TMT at HCG aims to establish a sustainable research enterprise for outcome-based research. It offers cost-effective clinical and non-clinical development services, putting HCG on the world map of oncology research.
The department supports all the in-house basic and clinical translational research and has an international second opinion network for patient benefit worldwide. Apart from the in-house research activities the department functions as an interface with the Pharma-Biotech industry and makes HCG their preferred partner in oncology drug development programs across the product life cycles. The department has developed a close relationship with the "Indian Society for Clinical Research (ISCR)" as an Accredited Member Organisation of the society.
Below listed are our focus areas:
Translational oncology – solid tumours and haemato-oncology
Tumour microenvironment interactions
Translational pathology and digital pathology
Genomic theragnostics (genotype-guided cancer therapy)
Diagnostics development and drug screening
Preventive oncology, community engagement and population science
The Department of Translational Medicine (TMT) provides services that promote a vibrant translational research and training environment at HCG.